Concord Medical Services Holdings Ltd represents values of excellence, compassion, and innovation in the healthcare industry. As a leading provider of specialty healthcare services in China, the company is committed to delivering high-quality medical care and enhancing patient experiences. With a corporate philosophy focused on integrity, social responsibility, and collaboration, Concord Medical Services aims to foster a positive impact on people's lives. Through continuous research and development, they strive to introduce advanced technologies and medical solutions, making healthcare more accessible and efficient. Concord Medical Services Holdings Ltd remains dedicated to improving the well-being of patients and driving sustainable growth in the healthcare sector.

Concord Medical Services Holdings Ltd primarily operates in China.

Since its establishment, Concord Medical Services Holdings Ltd has achieved several significant milestones. Notably, the company successfully listed on the New York Stock Exchange in 2009, enhancing its global visibility and access to capital markets. Concord Medical has developed a strong network comprising over 80 cooperative hospitals and medical centers, enabling it to provide high-quality healthcare services throughout China. With a commitment to technological advancements, the company implemented Proton Therapy, a cutting-edge treatment for cancer patients, becoming the first in China to offer this advanced therapy. Concord Medical continues to expand its services, collaborations, and medical achievements, solidifying its position as a leading provider of premier healthcare solutions.

Concord Medical Services Holdings Ltd is a leading healthcare provider in China. Established in 2000, the company specializes in operating network hospitals and offering advanced radiotherapy and diagnostic imaging services. Concord Medical Services Holdings Ltd has built a strong reputation for its state-of-the-art medical technology, dedicated healthcare professionals, and commitment to patient care. With a focus on cancer treatment, the company operates multiple comprehensive cancer centers across China. Concord Medical Services Holdings Ltd continues to expand its network and enhance its medical services to meet the growing healthcare needs of the Chinese population.

The main competitors of Concord Medical Services Holdings Ltd in the market include other healthcare providers and medical service companies, such as Beijing Tongshantang Hospital, Harmonicare Medical Holdings Ltd, and China Shineway Pharmaceutical Group Ltd. These companies also operate in the healthcare industry and offer similar services, creating competition for Concord Medical Services Holdings Ltd. It is important for investors and stakeholders to be aware of the competitive landscape in order to make informed decisions.

Concord Medical Services Holdings Ltd is primarily active in the healthcare industry.

The business model of Concord Medical Services Holdings Ltd revolves around providing comprehensive cancer diagnosis, treatment, and rehabilitation services in China. The company operates a network of radiotherapy and diagnostic imaging centers, partnering with renowned hospitals to deliver advanced medical technologies and high-quality healthcare services to patients. Concord Medical Services Holdings Ltd focuses on bridging the gaps in China's cancer care system by building a patient-centered platform that integrates medical resources, expertise, and innovative solutions. With a commitment to continuous improvement and patient satisfaction, the company strives to become a leading provider of specialized cancer care services in China.

De Concord Medical Services Holdings K/W is 0.

De Concord Medical Services Holdings KUV is 92,88.

De AlleAktien Kwaliteitsscore voor Concord Medical Services Holdings is 4/10.

De verwachte Concord Medical Services Holdings omzet is 64,25 mln. CNY.

De winst kan momenteel niet berekend worden voor Concord Medical Services Holdings.

Concord Medical Services Holdings Ltd is a leading Chinese provider of comprehensive cancer diagnosis and therapy solutions. The company offers a comprehensive range of services for patients, medical facilities, and research institutions. The business activities of Concord Medical Services are divided into two segments. On one hand, the company manufactures medical devices and instruments used for cancer diagnosis and treatment. These devices include imaging systems, radiotherapy machines, and specialized medical instruments for biological testing. On the other hand, Concord Medical Services provides management and consulting services for various medical facilities. This includes managing cancer centers, where Concord Medical Services supplies facilities with medical equipment, personnel, and financial services. This enables the facilities to improve their efficiency and enhance cancer patient care. To improve the quality of its medical products and services, Concord Medical Services collaborates with international partners. The company has partnerships with leading companies in the field of cancer diagnosis and treatment, such as Varian Medical Systems, Siemens, and General Electric. Concord Medical Services also operates its own research and development department to develop innovative technologies and products. The company aims to enhance diagnostic and therapeutic effectiveness while reducing the cost of treatment. Concord Medical Services also operates an online platform where patients and medical professionals can find comprehensive information about cancer diagnosis and therapy. This platform provides a wealth of online resources, such as medical articles, training videos, and case studies, to improve both patient education and medical training. Overall, the business model of Concord Medical Services is focused on providing high-quality and affordable cancer diagnosis and therapy solutions for patients and medical facilities. The company is able to offer a wide range of products and services through a combination of in-house production, partnerships, and research and development. The company continues to expand its business activities and expand its presence in the Chinese and international markets. As part of these efforts, Concord Medical Services has focused on new products and services in recent years, such as the development and marketing of personalized medical treatment for cancer patients. Overall, the business model of Concord Medical Services is long-term oriented and focused on sustainable development. The company's vision is to be a global leading brand in cancer diagnosis and therapy and to provide comprehensive value by supporting patients, medical professionals, and the broader society.

Concord Medical Services Holdings keert een dividend van 0 CNY uit, verdeeld over betalingen per jaar.

De dividend kan momenteel niet worden berekend voor Concord Medical Services Holdings of het bedrijf keert geen dividend uit.

De ISIN van Concord Medical Services Holdings is US2062771058.

Het WKN van Concord Medical Services Holdings is A0YF3D.

De ticker van Concord Medical Services Holdings is CCM.

Binnen de laatste 12 maanden betaalde Concord Medical Services Holdings een dividend van 0,99 CNY . Dit komt overeen met een dividendrendement van ongeveer 2,17 %. Voor de komende 12 maanden zal Concord Medical Services Holdings naar verwachting een dividend van 0 CNY betalen.

De dividendrendement van Concord Medical Services Holdings is momenteel 2,17 %.

Concord Medical Services Holdings betaalt elk kwartaal een dividend uit. Dit wordt uitgekeerd in de maanden februari, september, september, januari.

Concord Medical Services Holdings betaalde de afgelopen 0 jaar elk jaar dividend.

Voor de komende 12 maanden wordt een dividend van 0 CNY verwacht. Dit komt overeen met een dividendrendement van 0 %.

Concord Medical Services Holdings wordt toegewezen aan de sector 'Gezondheid'.

Om het laatste dividend van Concord Medical Services Holdings van 29-1-2016 ter hoogte van 0,99 CNY te ontvangen, moest je het aandeel voor de ex-datum op 23-12-2015 in je portefeuille hebben.

De laatste dividenduitkering vond plaats op 29-1-2016.

In het jaar 2023 heeft Concord Medical Services Holdings 0 CNY aan dividenden uitgekeerd.

De dividenden van Concord Medical Services Holdings worden in CNY uitgekeerd.